MedTrace Logo

The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma

NCT00644254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2009-07-07

No results posted yet for this study

Summary

Extracapsular lymph node involvement (ECLNI) has been identified as a pathological variable associated with worse outcome in esophageal, gastric and colorectal cancer. No studies so far have studied its prognostic impact in ductal pancreatic adenocarcinoma (DPAC). The goal of the investigators is to determine the prognostic value of ECLNI in a prospective consecutive series of 145 patients with DPAC, who underwent resection of their primary tumor between 1998 and 2005.

Conditions

  • Pancreatic Neoplasms
  • Pancreatic Adenocarcinoma

Interventions

PROCEDURE

Pancreatic resection

PPPD, Whipple, Total pancreatectomy or left pancreatectomy.

Sponsors & Collaborators

  • Agentschap voor Innovatie door Wetenschap en Technologie

    collaborator OTHER

  • KU Leuven

    lead OTHER

Principal Investigators

  • Baki Topal, MD, PhD · Catholic University Leuven (KULeuven), Belgium

  • Gregory Sergeant, MD · Catholic University Leuven, Belgium

  • Nadine Ectors, MD, PhD · Catholic University Leuven, Belgium

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-11-30
Completion
2008-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00644254 on ClinicalTrials.gov